NCT03396523 is a NA clinical trial of Losartan in Healthy, sponsored by University of Electronic Science and Technology of China.

Who is sponsoring NCT03396523?

NCT03396523 is sponsored by University of Electronic Science and Technology of China.

What drugs are being tested in NCT03396523?

Interventions in NCT03396523: Losartan, Placebo Oral Tablet.

Is NCT03396523 still recruiting?

NCT03396523 is currently status unknown. Last updated 6 June 2018.

Last reviewed 2018-06-06 · How we verify

NCT03396523

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Losartan and Emotion Processing

Status unknown NA Last updated 6 June 2018

What this trial tests

NA trial testing Losartan in Healthy in 70 participants. Status unknown.

Timeline

4 January 2018

Primary endpoint
31 October 2018

31 December 2018

Quick facts

Lead sponsor	University of Electronic Science and Technology of China
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	basic science
Enrollment	70
Start date	4 January 2018
Primary completion	31 October 2018
Estimated completion	31 December 2018
Sites	1 location across China

Drugs / interventions tested

Losartan (losartan) — full drug profile →
Placebo Oral Tablet — full drug profile →

Conditions studied

Healthy — all drugs for Healthy →

Sponsor

University of Electronic Science and Technology of China

Who can join

Adults 18 to 30, male only, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to investigate the effect of losartan (50mg, single dose) on the extinction of conditioned fear

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Human extinction learning is accelerated by an angiotensin antagonist via ventromedial prefrontal cortex and its connections with basolateral amygdala
Zhou F, Geng Y, Xin F, Li J, et al · · 2019 · DOI 10.1101/512657

Verify or expand the search:

Other trials of Losartan

Trials testing the same drug.

NCT06491940 — Comparison of the Role of Losartan Alone vs Hydrochlorothiazide Plus Losartan · NA · not yet recruiting
NCT06333522 — Losartan Use to Mitigate Arthrofibrosis Following Total Joint Arthroplasty · Phase 4 · withdrawn
NCT06150560 — A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial) · Phase 3 · recruiting
NCT06108063 — Mitigation of Arthrofibrosis After Total Knee Arthroplasty Using Losartan · Phase 1, PHASE2 · recruiting
NCT06329050 — The Effects of Losartan on Attention Control: An Eye-tracking Study · NA · recruiting

Other recruiting trials for Healthy

Currently open trials in the same condition.

NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting

Other University of Electronic Science and Technology of China trials

Trials by the same sponsor.

NCT07416370 — Neurofeedback Training of Anterior Insula Activity Based on Unidimensional vs. Multidimensional Interoceptive Regulation · NA · enrolling by invitation
NCT07389486 — Continuous vs. Intermittent Rt-fMRI Neurofeedback Training of the Anterior Insula · NA · recruiting
NCT07425938 — Oxytocin's Effects on Emotional Processing and Its Acting Routes · NA · recruiting
NCT07364084 — Real-time Neurofeedback Training of the Medial Prefrontal Cortex Based on Imagined Social Support · NA · recruiting
NCT07367672 — The Power of Belief: Expectation-driven and Placebo Modulation of Empathic Pain · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03396523 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Electronic Science and Technology of China
Last refreshed: 6 June 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03396523.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing